https://www.engineeringnews.co.za

Coronavac application at advanced stage, no decision on Sinopharm, Moderna – SAHPRA

Coronavac application at advanced stage, no decision on Sinopharm, Moderna – SAHPRA

Photo by Reuters

21st June 2021

By: Thabi Shomolekae

Creamer Media Senior Writer

     

Font size: - +

This article has been supplied.

The South African Health Products Regulatory Authority (SAHPRA) stressed on Monday that it could not approve any vaccines if an application is not submitted to the authority, as South Africa trails in its roll-out of Covid-19 vaccines.

However, the SAHPRA revealed that applications had been received for the Sputnik V and Sinovac’s Coronavac vaccines and that the evaluation of the Coronavac application is at an advanced stage.

The Sputnik V application is a rolling review, which the SAHPRA says is a mechanism that facilitates the submission of data as it becomes available.

“Whilst reviews can commence earlier with a rolling submission, it is important to note that some very important efficacy, quality and safety information is sometimes outstanding and would require review for consideration of such products for public use. Therefore, pharmaceutical companies can submit applications indicating a plan of when they will be submitting their data, i.e. outline when the next rolling submission sequence is available for review,” the authority explains.

SAHPRA has not made a decision on the Sinopharm and Moderna vaccines, which have a World Health Organization (WHO) Emergency Use Listing, as there have not been any applications for these vaccines in South Africa, the authority said.

SAHPRA has so far approved the Pfizer and the Johnson & Johnson vaccines for use in the country.

SAHPRA CEO Dr Boitumelo Semete-Makokotlela said the regulatory body would not be pressured to allow the public access to any product that had not met the necessary regulatory requirements.

The SAHPRA is concerned about the prevalence of other Covid-19 variants in South Africa, and is urging pharmaceutical companies to provide information on studies supporting efficacy with their vaccine applications.

Edited by Sashnee Moodley
Polity and Multimedia Managing Editor

Article Enquiry

Email Article

Save Article

Feedback

To advertise email advertising@creamermedia.co.za or click here

Showroom

Environmental Impact Management Services
Environmental Impact Management Services

EIMS is an independent specialised environmental consulting firm offering the full spectrum of environmental management services across all sectors...

VISIT SHOWROOM 
The Beneficiation Academy
The Beneficiation Academy

The Beneficiation Academy is a certified training institution that follows all compliance legislation and is accredited with various Sector...

VISIT SHOWROOM 

Latest Multimedia

sponsored by

Option 1 (equivalent of R125 a month):

Receive a weekly copy of Creamer Media's Engineering News & Mining Weekly magazine
(print copy for those in South Africa and e-magazine for those outside of South Africa)
Receive daily email newsletters
Access to full search results
Access archive of magazine back copies
Access to Projects in Progress
Access to ONE Research Report of your choice in PDF format

Option 2 (equivalent of R375 a month):

All benefits from Option 1
PLUS
Access to Creamer Media's Research Channel Africa for ALL Research Reports, in PDF format, on various industrial and mining sectors including Electricity; Water; Energy Transition; Hydrogen; Roads, Rail and Ports; Coal; Gold; Platinum; Battery Metals; etc.

Already a subscriber?

Forgotten your password?

MAGAZINE & ONLINE

SUBSCRIBE

RESEARCH CHANNEL AFRICA

SUBSCRIBE

CORPORATE PACKAGES

CLICK FOR A QUOTATION







301

sq:0.055 1.145s - 146pq - 2rq
Subscribe Now